NCT00306111View on ClinicalTrials.gov

Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2011

Conditions
Non-Hodgkin Lymphoma
Interventions
DRUG

pegfilgrastim

Single dose (6mg) one day after chemotherapy

Trial Locations (1)

72076

Dept. of Medicine 2, University of Tuebingen, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT00306111 - Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma | Biotech Hunter | Biotech Hunter